VAGELOS P ROY - 14 Mar 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/** P. Roy Vagelos
Issuer symbol
REGN
Transactions as of
14 Mar 2022
Net transactions value
-$18,086,665
Form type
4
Filing time
15 Mar 2022, 16:01:00 UTC
Previous filing
20 Dec 2021
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $13,434,750 +75,000 +24% $179.13* 393,669 14 Mar 2022 Direct
transaction REGN Common Stock Tax liability $31,521,415 -48,103 -12% $655.29 345,566 14 Mar 2022 Direct
transaction REGN Common Stock Gift $0 -338 -0.24% $0.000000 141,292 04 Jan 2022 by CLAT
holding REGN Common Stock 2,096 14 Mar 2022 By 401(k) Plan
holding REGN Common Stock 37,747 14 Mar 2022 by Spouse as Trustee
holding REGN Common Stock 3,609 14 Mar 2022 by trust for grandch F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -75,000 -100% $0.000000* 0 14 Mar 2022 Common Stock 75,000 $179.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.